COVID-19 Ad Intervention
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04555122|
Recruitment Status : Not yet recruiting
First Posted : September 18, 2020
Last Update Posted : September 23, 2020
|Condition or disease||Intervention/treatment||Phase|
|Social Distance||Behavioral: Social Distancing Advertisements||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||52500 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||COVID-19 Ad Intervention for Social Distancing|
|Estimated Study Start Date :||September 29, 2020|
|Estimated Primary Completion Date :||May 28, 2022|
|Estimated Study Completion Date :||July 28, 2022|
Experimental: Intervention Group
Advertisements will be sent to participants mobile devices to attempt to increase adherence to stay-at-home orders and social distancing. There are 3 types of advertisements. This will occur for 7 days.
Behavioral: Social Distancing Advertisements
Participants will receive 3 types of advertisements to increase social distancing/staying at home.
No Intervention: Control Group
Control Group will be people who will not receive any advertisements.
- Mobility [ Time Frame: 7 days ]Amount of time that participants are outside of their primary location/home
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04555122
|Contact: Arjuna Ugartefirstname.lastname@example.org|
|United States, California|
|Irvine, California, United States, 92617|
|Contact: Arjuna Dugarte email@example.com|